Cargando…

Circulating Renalase as Predictor of Renal and Cardiovascular Outcomes in Pre-Dialysis CKD Patients: A 5-Year Prospective Cohort Study

Chronic kidney disease (CKD) is an independent risk factor for adverse cardiovascular and cerebrovascular events (MACCEs), and mortality since the earlier stages. Therefore, it is critical to identify the link between CKD and cardiovascular risk (CVR) through early and reliable biomarkers. Acknowled...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerqueira, Ana, Quelhas-Santos, Janete, Ferreira, Inês, Sampaio, Susana, Relvas, Miguel, Marques, Nídia, Dias, Cláudia Camila, Pestana, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999882/
https://www.ncbi.nlm.nih.gov/pubmed/33800219
http://dx.doi.org/10.3390/life11030210
_version_ 1783670882407809024
author Cerqueira, Ana
Quelhas-Santos, Janete
Ferreira, Inês
Sampaio, Susana
Relvas, Miguel
Marques, Nídia
Dias, Cláudia Camila
Pestana, Manuel
author_facet Cerqueira, Ana
Quelhas-Santos, Janete
Ferreira, Inês
Sampaio, Susana
Relvas, Miguel
Marques, Nídia
Dias, Cláudia Camila
Pestana, Manuel
author_sort Cerqueira, Ana
collection PubMed
description Chronic kidney disease (CKD) is an independent risk factor for adverse cardiovascular and cerebrovascular events (MACCEs), and mortality since the earlier stages. Therefore, it is critical to identify the link between CKD and cardiovascular risk (CVR) through early and reliable biomarkers. Acknowledging that CKD and CKD progression are associated with increased sympathetic tone, which is implicated in CVR, and that renalase metabolizes catecholamines, we aimed to evaluate the relationship between renalase serum levels (RNLS) and cardiovascular and renal outcomes. The study included 40 pre-dialysis CKD patients (19F:21M) with median age of 61 (IQ 45–66) years. At baseline, we measured RNLS as well as routine biomarkers of renal and cardiovascular risk. A prospective analysis was performed to determine whether RNLS are associated with CKD progression, MACCEs, hospitalizations and all-cause mortality. At baseline, the median level of RNLS and median estimated glomerular filtration rate (eGFR) were 63.5 (IQ 48.4–82.7) µg/mL and 47 (IQ 13–119) mL/min/1.73 m(2), respectively. In univariate analysis, RNLS were strongly associated with eGFR, age and Charlson Index. Over the course of a mean follow-up of 65 (47 to 70) months, 3 (7.5%) deaths, 2 (5%) fatal MACCEs, 17 (42.5%) hospital admissions occurred, and 16 (40%) patients experienced CKD progression. In univariate analysis, RNLS were associated with CKD progression (p = 0.001), hospitalizations (p = 0.001) and all-cause mortality (p = 0.022) but not with MACCEs (p = 0.094). In adjusted analysis, RNLS predicted CKD progression and hospitalizations regardless of age, Charlson comorbidity index, cardiovascular disease, hypertension, diabetes and dyslipidemia. Our results suggest that RNLS, closely related with renal function, might have a potential role as predictor of renal outcomes, hospitalizations, and mortality in pre-dialysis CKD patients.
format Online
Article
Text
id pubmed-7999882
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79998822021-03-28 Circulating Renalase as Predictor of Renal and Cardiovascular Outcomes in Pre-Dialysis CKD Patients: A 5-Year Prospective Cohort Study Cerqueira, Ana Quelhas-Santos, Janete Ferreira, Inês Sampaio, Susana Relvas, Miguel Marques, Nídia Dias, Cláudia Camila Pestana, Manuel Life (Basel) Article Chronic kidney disease (CKD) is an independent risk factor for adverse cardiovascular and cerebrovascular events (MACCEs), and mortality since the earlier stages. Therefore, it is critical to identify the link between CKD and cardiovascular risk (CVR) through early and reliable biomarkers. Acknowledging that CKD and CKD progression are associated with increased sympathetic tone, which is implicated in CVR, and that renalase metabolizes catecholamines, we aimed to evaluate the relationship between renalase serum levels (RNLS) and cardiovascular and renal outcomes. The study included 40 pre-dialysis CKD patients (19F:21M) with median age of 61 (IQ 45–66) years. At baseline, we measured RNLS as well as routine biomarkers of renal and cardiovascular risk. A prospective analysis was performed to determine whether RNLS are associated with CKD progression, MACCEs, hospitalizations and all-cause mortality. At baseline, the median level of RNLS and median estimated glomerular filtration rate (eGFR) were 63.5 (IQ 48.4–82.7) µg/mL and 47 (IQ 13–119) mL/min/1.73 m(2), respectively. In univariate analysis, RNLS were strongly associated with eGFR, age and Charlson Index. Over the course of a mean follow-up of 65 (47 to 70) months, 3 (7.5%) deaths, 2 (5%) fatal MACCEs, 17 (42.5%) hospital admissions occurred, and 16 (40%) patients experienced CKD progression. In univariate analysis, RNLS were associated with CKD progression (p = 0.001), hospitalizations (p = 0.001) and all-cause mortality (p = 0.022) but not with MACCEs (p = 0.094). In adjusted analysis, RNLS predicted CKD progression and hospitalizations regardless of age, Charlson comorbidity index, cardiovascular disease, hypertension, diabetes and dyslipidemia. Our results suggest that RNLS, closely related with renal function, might have a potential role as predictor of renal outcomes, hospitalizations, and mortality in pre-dialysis CKD patients. MDPI 2021-03-08 /pmc/articles/PMC7999882/ /pubmed/33800219 http://dx.doi.org/10.3390/life11030210 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Article
Cerqueira, Ana
Quelhas-Santos, Janete
Ferreira, Inês
Sampaio, Susana
Relvas, Miguel
Marques, Nídia
Dias, Cláudia Camila
Pestana, Manuel
Circulating Renalase as Predictor of Renal and Cardiovascular Outcomes in Pre-Dialysis CKD Patients: A 5-Year Prospective Cohort Study
title Circulating Renalase as Predictor of Renal and Cardiovascular Outcomes in Pre-Dialysis CKD Patients: A 5-Year Prospective Cohort Study
title_full Circulating Renalase as Predictor of Renal and Cardiovascular Outcomes in Pre-Dialysis CKD Patients: A 5-Year Prospective Cohort Study
title_fullStr Circulating Renalase as Predictor of Renal and Cardiovascular Outcomes in Pre-Dialysis CKD Patients: A 5-Year Prospective Cohort Study
title_full_unstemmed Circulating Renalase as Predictor of Renal and Cardiovascular Outcomes in Pre-Dialysis CKD Patients: A 5-Year Prospective Cohort Study
title_short Circulating Renalase as Predictor of Renal and Cardiovascular Outcomes in Pre-Dialysis CKD Patients: A 5-Year Prospective Cohort Study
title_sort circulating renalase as predictor of renal and cardiovascular outcomes in pre-dialysis ckd patients: a 5-year prospective cohort study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999882/
https://www.ncbi.nlm.nih.gov/pubmed/33800219
http://dx.doi.org/10.3390/life11030210
work_keys_str_mv AT cerqueiraana circulatingrenalaseaspredictorofrenalandcardiovascularoutcomesinpredialysisckdpatientsa5yearprospectivecohortstudy
AT quelhassantosjanete circulatingrenalaseaspredictorofrenalandcardiovascularoutcomesinpredialysisckdpatientsa5yearprospectivecohortstudy
AT ferreiraines circulatingrenalaseaspredictorofrenalandcardiovascularoutcomesinpredialysisckdpatientsa5yearprospectivecohortstudy
AT sampaiosusana circulatingrenalaseaspredictorofrenalandcardiovascularoutcomesinpredialysisckdpatientsa5yearprospectivecohortstudy
AT relvasmiguel circulatingrenalaseaspredictorofrenalandcardiovascularoutcomesinpredialysisckdpatientsa5yearprospectivecohortstudy
AT marquesnidia circulatingrenalaseaspredictorofrenalandcardiovascularoutcomesinpredialysisckdpatientsa5yearprospectivecohortstudy
AT diasclaudiacamila circulatingrenalaseaspredictorofrenalandcardiovascularoutcomesinpredialysisckdpatientsa5yearprospectivecohortstudy
AT pestanamanuel circulatingrenalaseaspredictorofrenalandcardiovascularoutcomesinpredialysisckdpatientsa5yearprospectivecohortstudy